FUKOKU MUTUAL LIFE INSURANCE Co Has $12.65 Million Stake in CME Group Inc. $CME

Key Points

• FUKOKU MUTUAL LIFE INSURANCE Co boosted its CME Group stake by 2,935.8% in the fourth quarter, ending with 46,327 shares valued at about $12.65 million.
• CME Group reported strong quarterly results, with earnings of $3.36 per share beating estimates and revenue of $1.88 billion also topping forecasts; revenue rose 14.5% year over year.
• The company announced a quarterly dividend of $1.30 per share, and analysts currently rate the stock Moderate Buy with a consensus price target of $305.29.

FUKOKU MUTUAL LIFE INSURANCE Co grew its stake in CME Group Inc. (NASDAQ:CME - Free Report) by 2,935.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 46,327 shares of the financial services provider's stock after purchasing an additional 44,801 shares during the period. FUKOKU MUTUAL LIFE INSURANCE Co's holdings in CME Group were worth $12,651,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently bought and sold shares of the stock. Truist Financial Corp lifted its holdings in shares of CME Group by 8.9% during the 3rd quarter. Truist Financial Corp now owns 70,712 shares of the financial services provider's stock worth $19,106,000 after acquiring an additional 5,773 shares during the period. Ashton Thomas Private Wealth LLC lifted its holdings in CME Group by 78.8% during the 3rd quarter. Ashton Thomas Private Wealth LLC now owns 13,281 shares of the financial services provider's stock valued at $3,588,000 after purchasing an additional 5,855 shares during the last quarter. SG Americas Securities LLC lifted its holdings in CME Group by 345.2% during the 4th quarter. SG Americas Securities LLC now owns 237,898 shares of the financial services provider's stock valued at $64,965,000 after purchasing an additional 184,459 shares during the last quarter. Dover Advisors LLC lifted its holdings in CME Group by 95.5% during the 3rd quarter. Dover Advisors LLC now owns 5,597 shares of the financial services provider's stock valued at $1,512,000 after purchasing an additional 2,734 shares during the last quarter. Finally, Keybank National Association OH lifted its holdings in CME Group by 15.4% during the 3rd quarter. Keybank National Association OH now owns 153,625 shares of the financial services provider's stock valued at $41,508,000 after purchasing an additional 20,477 shares during the last quarter. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on the stock. Deutsche Bank Aktiengesellschaft cut their price target on shares of CME Group from $342.00 to $322.00 and set a "buy" rating for the company in a report on Thursday, April 23rd. Barclays cut their price target on shares of CME Group from $343.00 to $316.00 and set an "equal weight" rating for the company in a report on Thursday, April 23rd. Argus reissued a "hold" rating on shares of CME Group in a report on Wednesday, March 4th. Rothschild & Co Redburn cut their price target on shares of CME Group from $340.00 to $316.00 and set a "neutral" rating for the company in a report on Monday, April 27th. Finally, UBS Group reissued a "neutral" rating and set a $310.00 price target on shares of CME Group in a report on Friday, February 6th. Two investment analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating, six have given a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, CME Group has a consensus rating of "Moderate Buy" and a consensus target price of $305.29.

CME Group Trading Down 0.6%

CME opened at $277.42 on Friday. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. The company has a market cap of $100.53 billion, a price-to-earnings ratio of 23.67, a price-to-earnings-growth ratio of 3.12 and a beta of 0.23. The firm has a 50 day simple moving average of $293.99 and a 200 day simple moving average of $289.62. CME Group Inc. has a fifty-two week low of $257.17 and a fifty-two week high of $329.16.

CME Group (NASDAQ:CME - Get Free Report) last posted its quarterly earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share for the quarter, topping analysts' consensus estimates of $3.11 by $0.25. The business had revenue of $1.88 billion during the quarter, compared to the consensus estimate of $1.77 billion. CME Group had a net margin of 63.19% and a return on equity of 15.42%. CME Group's revenue for the quarter was up 14.5% compared to the same quarter last year. During the same period in the previous year, the firm posted $2.80 earnings per share. On average, sell-side analysts anticipate that CME Group Inc. will post 12.28 earnings per share for the current year.

CME Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, June 25th. Investors of record on Tuesday, June 9th will be issued a dividend of $1.30 per share. The ex-dividend date is Tuesday, June 9th. This represents a $5.20 dividend on an annualized basis and a yield of 1.9%. CME Group's payout ratio is currently 44.37%.

Insider Activity at CME Group

In related news, insider Hilda Harris Piell sold 5,753 shares of the business's stock in a transaction that occurred on Monday, May 18th. The shares were sold at an average price of $304.63, for a total transaction of $1,752,536.39. Following the completion of the transaction, the insider owned 27,702 shares in the company, valued at approximately $8,438,860.26. The trade was a 17.20% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, General Counsel Jonathan L. Marcus sold 3,291 shares of the business's stock in a transaction that occurred on Tuesday, March 17th. The shares were sold at an average price of $333.37, for a total transaction of $1,097,120.67. Following the transaction, the general counsel owned 7,192 shares of the company's stock, valued at approximately $2,397,597.04. This represents a 31.39% decrease in their position. The SEC filing for this sale provides additional information. Over the last 90 days, insiders sold 44,044 shares of company stock worth $13,297,507. 0.30% of the stock is currently owned by company insiders.

CME Group Profile

CME Group Inc is a global markets company that operates some of the world's largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company's core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.